Trial Profile
The effect of birch pollen immunotherapy on hazelnut allergy evaluated by DBPCFC with hazelnut.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Oct 2014
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Asthma; Food hypersensitivity
- Focus Therapeutic Use
- 29 Jul 2009 New trial record